Eventide Exponential Technologies Fund earns a Low Process Pillar rating. The predominant detractor from the rating is the parent firm's five-year risk-adjusted success ratio of 40%. The measure ...

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Evolent Health, Inc. (NYSE:EVH – Free Report) during ...

Eventide practices "value-based" investing. This involves screens (both faith-based and secular) that exclude stocks with ties to abortion, pornography, tobacco, and weapons, as well as the firm's ...

The Best of All Worlds tour, which saw Sammy Hagar, Michael Anthony, and Jason Bonham team up to deliver a celebration of Van ...

Fintel reports that on March 20, 2025, Morgan Stanley initiated coverage of Celldex Therapeutics (NasdaqCM:CLDX) with a ...

As the guitarist prepares for the Van Halen tribute's Las Vegas residency, he shared the numerous difficulties he faced ...

The Fund seeks to provide long-term capital appreciation. The Fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity and equity-related securities of ...

Analysts at William Blair raised their Q1 2025 EPS estimates for Nektar Therapeutics in a research report issued to clients and investors on Thursday, March 13th. William Blair analyst A. Hsieh now ...

Beaches Resorts has announced a near US$1-billion expansion that will see the construction of three new properties across ...

Lent 2025 started on Wednesday, March 5 with Ash Wednesday.

The Fund seeks to provide long-term capital appreciation. The Fund invests primarily in a broad range of equity securities without limitation to market capitalization. The Fund seeks to invest in ...